NCT03652844 is a NA clinical trial of AAM in Age-Related Atrophy, sponsored by Musculoskeletal Transplant Foundation.

Who is sponsoring NCT03652844?

NCT03652844 is sponsored by Musculoskeletal Transplant Foundation.

What drugs are being tested in NCT03652844?

Interventions in NCT03652844: AAM.

What condition does NCT03652844 study?

NCT03652844 studies Age-Related Atrophy.

Is NCT03652844 still recruiting?

NCT03652844 is currently completed. Last updated 11 May 2021.

Last reviewed 2021-05-11 · How we verify

NCT03652844

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Use of AAM for Correction of Age Related Volume Deficits in the Face

Completed NA Last updated 11 May 2021

What this trial tests

NA trial testing AAM in Age-Related Atrophy in 24 participants. Completed in 12 July 2019.

Timeline

27 August 2018

Primary endpoint
12 July 2019

12 July 2019

Quick facts

Lead sponsor	Musculoskeletal Transplant Foundation
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	24
Start date	27 August 2018
Primary completion	12 July 2019
Estimated completion	12 July 2019
Sites	3 locations across United States

Drugs / interventions tested

Conditions studied

Age-Related Atrophy — all drugs for Age-Related Atrophy →

Sponsor

Musculoskeletal Transplant Foundation

Who can join

Adults 30 to 70, any sex, with Age-Related Atrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate Allograft Adipose Matrix (AAM) in the face of people with age-related volume deficit - fat loss. AAM is a tissue used to correct fat loss. Participation in this study requires injections for placing AAM in the bilateral pre-jowl and malar areas of the face. The research will tell whether AAM is effective in maintaining mid-face fullness and whether the appearance of the skin improves after injection.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A Multicenter Pilot Study of a Novel Allograft Adipose Matrix in Malar and Prejowl Volume Restoration
Gold M, Fagien S, Rohrich R. · · 2024

Verify or expand the search:

Other recruiting trials for Age-Related Atrophy

Currently open trials in the same condition.

NCT06363942 — A Personalized Video-based Exercise Program for Fall Prevention in Frail and Pre-frail Older Adult · NA · recruiting

Other Musculoskeletal Transplant Foundation trials

Trials by the same sponsor.

NCT05566808 — Use of Allograft Cartilage in Cosmetic and Reconstructive Rhinoplasty · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03652844 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Musculoskeletal Transplant Foundation
Last refreshed: 11 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03652844.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing